Home/Filings/4/0001209191-22-043770
4//SEC Filing

Derovan Netanel 4

Accession 0001209191-22-043770

CIK 0001176309other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 8:00 PM ET

Size

5.0 KB

Accession

0001209191-22-043770

Insider Transaction Report

Form 4
Period: 2022-07-28
Derovan Netanel
Chief Legal Officer
Transactions
  • Award

    Common Stock

    2022-07-28+30,00048,000 total
Footnotes (1)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001901330

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 8:00 PM ET
Size
5.0 KB